In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has ...
A TRPM8 agonist that targets corneal sensory nerves can increase and sustain tear production in patients with dry eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback